264 related articles for article (PubMed ID: 12905801)
1. [Telomerase expression in various lesions of adrenal cortex].
Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland.
Sasano H; Sato F; Shizawa S; Nagura H; Coughtrie MW
Mod Pathol; 1995 Dec; 8(9):891-6. PubMed ID: 8751327
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of glutathione-peroxidase (GSH-PO) in human adrenal gland--studies on adrenocortical adenomas associated with primary aldosteronism and Cushing's syndrome.
Murakoshi M; Osamura RY; Yoshimura S; Watanabe K
Tokai J Exp Clin Med; 1995 Jul; 20(2):89-97. PubMed ID: 8797265
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
5. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia.
Karasawa R; Hotta M; Aiba M; Takano K
Pathol Int; 2004 Apr; 54(4):273-8. PubMed ID: 15028030
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in benign and malignant adrenal tumors.
Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
[TBL] [Abstract][Full Text] [Related]
11. Expression of telomerase (hTERT) in aldosterone-producing adrenocortical tumors.
Sticchi D; Fassina A; Ganzaroli C; Pasqualetto C; Pessina AC; Nussdorfer GG; Rossi GP
Int J Mol Med; 2006 Mar; 17(3):469-74. PubMed ID: 16465394
[TBL] [Abstract][Full Text] [Related]
12. Vascularity in human adrenal cortex.
Sasano H; Ohashi Y; Suzuki T; Nagura H
Mod Pathol; 1998 Apr; 11(4):329-33. PubMed ID: 9578082
[TBL] [Abstract][Full Text] [Related]
13. Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Murakoshi M; Osamura Y; Watanabe K; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1983 Jul; 8(3):293-300. PubMed ID: 6322390
[TBL] [Abstract][Full Text] [Related]
14. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity as an indicator of potentially malignant adrenal tumors.
Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; Tsuda F
Cancer; 1998 Aug; 83(4):772-6. PubMed ID: 9708944
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical tumorigenesis.
Beuschlein F; Reincke M
Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
[TBL] [Abstract][Full Text] [Related]
18. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
19. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutathione-S-transferase A1 in benign adrenocortical adenomas from patients with Cushing's syndrome.
Sarkar D; Imai T; Kambe F; Shibata A; Ohmori S; Hayasaka S; Funahashi H; Seo H
J Clin Endocrinol Metab; 2001 Apr; 86(4):1653-9. PubMed ID: 11297599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
